UK weighs putting "one-week key diagnostics access" into law
This article was originally published in Clinica
Executive Summary
As the UK's mainstream media focus on government proposals to enshrine into law its pledges on elective surgery and cancer referral waits, other guarantees mooted today promise to go even further in improving access to medtech. A "right to key diagnostic tests for suspected cancer patients within one week of seeing a GP, with an interim milestone of two weeks" is among the targets put forward for future inclusion in the NHS Constitution, building on plans announced in September.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.